The Western Union Company offers an attractive 11% dividend yield, prompting concerns about underlying business risks or market skepticism. Despite negative sentiment and "dying business" narratives, WU's recent earnings release provides a timely opportunity to reassess its prospects. I rate WU as a Buy, highlighting its appeal to dividend seekers, value investors, and those interested in its stablecoin fintech initiative.

RCI posts a solid Q3 earnings beat on higher revenue and Media growth while raising its 2025 free cash flow outlook.

Orla Mining (ORLA) possesses solid growth attributes, which could help it handily outperform the market.

Badger Meter (BMI) could produce exceptional returns because of its solid growth attributes.

SAN FRANCISCO , Oct. 24, 2025 /PRNewswire/ -- A securities class action, styled Bridgewood v. MoonLake Immunotherapeutics, et al.

LFMD Investors with Losses Encouraged to Contact Hagens Berman Before Oct. 27th Deadline SAN FRANCISCO , Oct. 24, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives provided investors with a misleading picture of its financial health and growth prospects. The suit, filed in in the Eastern District of New York, comes after a dramatic stock price decline in August following the company's earnings report.

Visa (V) remains a top portfolio holding, benefiting from secular growth in digital payments and unmatched profit margins over 50%. Q4 FY2025 results are expected to show low-double digit growth across all segments, with 'Other' revenue growing over 22% year-over-year. V's valuation is in line with historical averages, limiting new buying opportunities despite strong fundamentals and consistent share repurchases.

Dallas, TX, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Vivakor, Inc. (“Vivakor” or the “Company”) (Nasdaq: VIVK), an integrated energy infrastructure & environmental services company, today announced that it has entered into securities purchase agreements with a single fundamental institutional investor for the purchase and sale of 10,909,090 shares of its common stock and 5,000,000 pre-funded warrants in a registered direct offering, for gross proceeds of approximately $3.5 million, before deducting commissions and offering expenses. The closing of the offering is expected to occur on or about October 27, 2025, subject to the satisfaction of customary closing conditions.

Sanofi (SNY) remains a Buy, driven by Dupixent's robust growth and expanding indications, notably with the recent COPD launch. SNY's Q3 saw total revenues rise 7% CER to €12.43 billion, with Dupixent contributing over €4 billion for the first time. Beyond Dupixent, SNY is diversifying with specialty launches like Altuviiio in hemophilia and Beyfortus in RSV, plus a strong pipeline and share buybacks.

Eastern Bankshares, Inc. (NASDAQ:EBC ) Q3 2025 Earnings Call October 24, 2025 9:00 AM EDT Company Participants Robert Rivers - Executive Chairman of the Board Denis Sheahan - CEO & Director R. Rosato - CFO & Treasurer Conference Call Participants Damon Del Monte - Keefe, Bruyette, & Woods, Inc., Research Division Mark Fitzgibbon - Piper Sandler & Co., Research Division Laura Havener Hunsicker - Seaport Research Partners Sun Young Lee - TD Cowen, Research Division Presentation Operator Welcome to the Eastern Bankshares, Inc. Third Quarter 2025 Earnings Conference Call.

Southside Bancshares, Inc. (NYSE:SBSI ) Q3 2025 Earnings Call October 24, 2025 12:00 PM EDT Company Participants Lee Gibson - CEO & Director Keith Donahoe - President Julie Shamburger - Chief Financial Officer Conference Call Participants Michael Rose - CGS International Michael Rose - Raymond James & Associates, Inc., Research Division Wood Lay - Keefe, Bruyette, & Woods, Inc., Research Division Jordan Ghent - Stephens Inc., Research Division Presentation Operator [Audio Gap] our current forward-looking assumptions are described in our earnings release and our Form 10-K. Joining me today are Lee Gibson, CEO; Keith Donahoe, President and CFO, Julie Shamburger.

Sanofi (SAN:CA) Q3 2025 Earnings Call Transcript

SAN FRANCISCO , Oct. 24, 2025 /PRNewswire/ -- A new class action complaint has been filed against aTyr Pharma, Inc. (NASDAQ: ATYR) and certain of its top executives, significantly enlarging the alleged class period covered by the ongoing securities litigation. The new class action, King v.

CYH's Q3 earnings surge on higher same-store admissions, cost cuts and a stronger payor mix, swinging to a $171M profit from a loss last year.

POOL's Q3 earnings and revenues beat estimates, driven by steady maintenance demand and digital expansion momentum.

EQT completed the Equitrans acquisition in the third quarter of fiscal year 2024. The addition of midstream assets, notably the Mountain Valley Pipeline, improved realized natural gas prices and reduced exposure to oversupplied markets. Year-to-date, both transportation/processing and other operating costs declined.

A consortium of Grindr shareholders who own more than 60% of its outstanding shares, including George Raymond Zage III and James Fu Bin Lu, has submitted a non-binding proposal to take the dating app private, offering $18 per share.

Customers Bancorp, Inc. (NYSE:CUBI ) Q3 2025 Earnings Call October 24, 2025 9:00 AM EDT Company Participants Philip Watkins - EVP, Head of Corporate Development & Investor Relations Jay Sidhu - Founder, Chairman & CEO Samvir Sidhu - President Mark McCollom - Executive VP & CFO Conference Call Participants Sun Young Lee - TD Cowen, Research Division Stephen Moss - Raymond James & Associates, Inc., Research Division Peter Winter - D.A. Davidson & Co., Research Division David Bishop - Hovde Group, LLC, Research Division Kelly Motta - Keefe, Bruyette, & Woods, Inc., Research Division Harold Goetsch - B.

STMicroelectronics (STM) is rated a 'Buy', reflecting long-term recovery potential despite recent underperformance. STM's automotive and industrial end market exposure has driven volatility, but signs of recovery are emerging, especially in automotive revenue. Risks include uncertain timing for full recovery, peer competition (notably peers mentioned within), and ongoing macro/geopolitical challenges.